Report Detail
Global Buprenorphine Transdermal Patches Market Insights, Forecast to 2025
- RnM2439086 |
- 20 March, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
The global Buprenorphine Transdermal Patches market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Buprenorphine Transdermal Patches market based on company, product type, end user and key regions.
This report studies the global market size of Buprenorphine Transdermal Patches in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Buprenorphine Transdermal Patches in these regions.
This research report categorizes the global Buprenorphine Transdermal Patches market by top players/brands, region, type and end user. This report also studies the global Buprenorphine Transdermal Patches market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Grunenthal
PurduePharma
Luye Pharma
Market size by Product
5mcg/h
7.5mcg/h
10mcg/h
15 mcg/h
20 mcg/h
Market size by End User
Relieve Cancer Pain
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Buprenorphine Transdermal Patches market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Buprenorphine Transdermal Patches market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Buprenorphine Transdermal Patches companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Buprenorphine Transdermal Patches submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Buprenorphine Transdermal Patches are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Buprenorphine Transdermal Patches market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Buprenorphine Transdermal Patches Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Buprenorphine Transdermal Patches Market Size Growth Rate by Product
- 1.4.2 5mcg/h
- 1.4.3 7.5mcg/h
- 1.4.4 10mcg/h
- 1.4.5 15 mcg/h
- 1.4.6 20 mcg/h
- 1.5 Market by End User
- 1.5.1 Global Buprenorphine Transdermal Patches Market Size Growth Rate by End User
- 1.5.2 Relieve Cancer Pain
- 1.5.3 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Buprenorphine Transdermal Patches Market Size
- 2.1.1 Global Buprenorphine Transdermal Patches Revenue 2014-2025
- 2.1.2 Global Buprenorphine Transdermal Patches Sales 2014-2025
- 2.2 Buprenorphine Transdermal Patches Growth Rate by Regions
- 2.2.1 Global Buprenorphine Transdermal Patches Sales by Regions
- 2.2.2 Global Buprenorphine Transdermal Patches Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Buprenorphine Transdermal Patches Sales by Manufacturers
- 3.1.1 Buprenorphine Transdermal Patches Sales by Manufacturers
- 3.1.2 Buprenorphine Transdermal Patches Sales Market Share by Manufacturers
- 3.1.3 Global Buprenorphine Transdermal Patches Market Concentration Ratio (CR5 and HHI)
- 3.2 Buprenorphine Transdermal Patches Revenue by Manufacturers
- 3.2.1 Buprenorphine Transdermal Patches Revenue by Manufacturers (2014-2019)
- 3.2.2 Buprenorphine Transdermal Patches Revenue Share by Manufacturers (2014-2019)
- 3.3 Buprenorphine Transdermal Patches Price by Manufacturers
- 3.4 Buprenorphine Transdermal Patches Manufacturing Base Distribution, Product Types
- 3.4.1 Buprenorphine Transdermal Patches Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Buprenorphine Transdermal Patches Product Type
- 3.4.3 Date of International Manufacturers Enter into Buprenorphine Transdermal Patches Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Buprenorphine Transdermal Patches Sales by Product
- 4.2 Global Buprenorphine Transdermal Patches Revenue by Product
- 4.3 Buprenorphine Transdermal Patches Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Buprenorphine Transdermal Patches Breakdown Data by End User
6 North America
- 6.1 North America Buprenorphine Transdermal Patches by Countries
- 6.1.1 North America Buprenorphine Transdermal Patches Sales by Countries
- 6.1.2 North America Buprenorphine Transdermal Patches Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Buprenorphine Transdermal Patches by Product
- 6.3 North America Buprenorphine Transdermal Patches by End User
7 Europe
- 7.1 Europe Buprenorphine Transdermal Patches by Countries
- 7.1.1 Europe Buprenorphine Transdermal Patches Sales by Countries
- 7.1.2 Europe Buprenorphine Transdermal Patches Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Buprenorphine Transdermal Patches by Product
- 7.3 Europe Buprenorphine Transdermal Patches by End User
8 Asia Pacific
- 8.1 Asia Pacific Buprenorphine Transdermal Patches by Countries
- 8.1.1 Asia Pacific Buprenorphine Transdermal Patches Sales by Countries
- 8.1.2 Asia Pacific Buprenorphine Transdermal Patches Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Buprenorphine Transdermal Patches by Product
- 8.3 Asia Pacific Buprenorphine Transdermal Patches by End User
9 Central & South America
- 9.1 Central & South America Buprenorphine Transdermal Patches by Countries
- 9.1.1 Central & South America Buprenorphine Transdermal Patches Sales by Countries
- 9.1.2 Central & South America Buprenorphine Transdermal Patches Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Buprenorphine Transdermal Patches by Product
- 9.3 Central & South America Buprenorphine Transdermal Patches by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Buprenorphine Transdermal Patches by Countries
- 10.1.1 Middle East and Africa Buprenorphine Transdermal Patches Sales by Countries
- 10.1.2 Middle East and Africa Buprenorphine Transdermal Patches Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Buprenorphine Transdermal Patches by Product
- 10.3 Middle East and Africa Buprenorphine Transdermal Patches by End User
11 Company Profiles
- 11.1 Grunenthal
- 11.1.1 Grunenthal Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Grunenthal Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Grunenthal Buprenorphine Transdermal Patches Products Offered
- 11.1.5 Grunenthal Recent Development
- 11.2 PurduePharma
- 11.2.1 PurduePharma Company Details
- 11.2.2 Company Business Overview
- 11.2.3 PurduePharma Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 PurduePharma Buprenorphine Transdermal Patches Products Offered
- 11.2.5 PurduePharma Recent Development
- 11.3 Luye Pharma
- 11.3.1 Luye Pharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Luye Pharma Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Luye Pharma Buprenorphine Transdermal Patches Products Offered
- 11.3.5 Luye Pharma Recent Development
12 Future Forecast
- 12.1 Buprenorphine Transdermal Patches Market Forecast by Regions
- 12.1.1 Global Buprenorphine Transdermal Patches Sales Forecast by Regions 2019-2025
- 12.1.2 Global Buprenorphine Transdermal Patches Revenue Forecast by Regions 2019-2025
- 12.2 Buprenorphine Transdermal Patches Market Forecast by Product
- 12.2.1 Global Buprenorphine Transdermal Patches Sales Forecast by Product 2019-2025
- 12.2.2 Global Buprenorphine Transdermal Patches Revenue Forecast by Product 2019-2025
- 12.3 Buprenorphine Transdermal Patches Market Forecast by End User
- 12.4 North America Buprenorphine Transdermal Patches Forecast
- 12.5 Europe Buprenorphine Transdermal Patches Forecast
- 12.6 Asia Pacific Buprenorphine Transdermal Patches Forecast
- 12.7 Central & South America Buprenorphine Transdermal Patches Forecast
- 12.8 Middle East and Africa Buprenorphine Transdermal Patches Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Buprenorphine Transdermal Patches Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Buprenorphine Transdermal Patches . Industry analysis & Market Report on Buprenorphine Transdermal Patches is a syndicated market report, published as Global Buprenorphine Transdermal Patches Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Buprenorphine Transdermal Patches market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
